Key facts
- This page summarizes Jonathan Rubin's Form 4 filing for SUPERNUS PHARMACEUTICALS, INC. (SUPN).
- 6 reported transactions and 2 derivative rows are listed below.
- Filing timestamp: 30 Dec 2024, 16:13.
Jonathan Rubin - 27 Dec 2024 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)
- Signature
- /s/ Timothy C. Dec, as attorney-in-fact
- Issuer symbol
- SUPN
- Transactions as of
- 27 Dec 2024
- Net transactions value
- -$39,220
- Form type
- 4
- Filing time
- 30 Dec 2024, 16:13:12 UTC
- Previous filing
- 26 Dec 2024
- Next filing
- 29 Jan 2025
- SEC
- View on sec.gov
Key filing fact
Jonathan Rubin filed Form 4 for SUPERNUS PHARMACEUTICALS, INC. (SUPN) on 30 Dec 2024.
Change
- Previous filing in this sequence was filed on 26 Dec 2024.
- Current net transaction value: -$39,220.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Transactions Table
SUPN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +750
- Change %
- +15%
- Price
- $0.000000
- Shares after
- 5,822
- Date
- 27 Dec 2024
- Ownership
- Direct
- Footnotes
- F1, F2
SUPN
transaction
Common Stock
Tax liability
- Transaction value
- $10,001
- Shares
- -281
- Change %
- -4.8%
- Price
- $35.59
- Shares after
- 5,541
- Date
- 27 Dec 2024
- Ownership
- Direct
- Footnotes
- F3
SUPN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +1,875
- Change %
- +34%
- Price
- $0.000000
- Shares after
- 7,416
- Date
- 27 Dec 2024
- Ownership
- Direct
- Footnotes
- F4
SUPN
transaction
Common Stock
Tax liability
- Transaction value
- $29,219
- Shares
- -821
- Change %
- -11%
- Price
- $35.59
- Shares after
- 6,595
- Date
- 27 Dec 2024
- Ownership
- Direct
- Footnotes
- F3
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
SUPN
transaction
Derivative
Performance Share Unit
Options Exercise
- Transaction value
- $0
- Shares
- -750
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 27 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 750
- Exercise price
- $0.000000
- Footnotes
- F5
SUPN
transaction
Derivative
Performance Share Unit
Options Exercise
- Transaction value
- $0
- Shares
- -1,875
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 27 Dec 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,875
- Exercise price
- $0.000000
- Footnotes
- F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 23, 2023. |
| F2 | Includes an aggregate of 431 shares acquired by the Reporting Person through the Issuer's Employee Stock Purchase Plan. |
| F3 | Represents the number of shares of common stock withheld by the Company to satisfy tax withholding requirements in connection with the vesting of Performance Share Units. |
| F4 | Shares of common stock received upon the settlement of certain Performance Share Units granted to the Reporting Person on February 22, 2024. |
| F5 | On February 23, 2023, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 12, 2023 and modified on December 12, 2024. |
| F6 | On February 22, 2024, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period, which objectives were established on June 24, 2024. |